Preclinical Models of Graves’ Disease and Associated Secondary Complications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|18|2414-2421

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.18, 2015-06, pp. : 2414-2421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The significance of non-human primates as preclinical models of human arthritic disease

By Vierboom Michel   Breedveld Elia   Kondova Ivanela   't Hart Bert A  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 299-310

Informa Healthcare

Access to resources Recommend Favorite

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

By Jankovic Joseph  

CNS Drugs, Vol. 21, Iss. 8, 2007-01 ,pp. : 677-692

Adis International

Access to resources Recommend Favorite

Medical therapies for Graves' disease reviewed

By  

Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Thiamazole tops propylthiouracil for Graves' disease

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Emerging pharmacotherapy for treatment of Graves' disease

By Bahn Rebecca S  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 605-607

Informa Healthcare

Access to resources Recommend Favorite